Home World News Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised... World News Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised TNBC By Ogkologos - May 19, 2026 300 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PLANeT study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR One Dose of Either a Bivalent or Nonavalent HPV Vaccine Provides... December 9, 2025 Understanding Genomic Correlates of Response and Acquired Resistance to FGFR Inhibitors January 28, 2025 Adding Atezolizumab to First-Line Bevacizumab Plus Platinum Regimen Improves Survival in... December 12, 2023 Intensive Program Helps People Being Screened for Lung Cancer Quit Smoking March 21, 2025 Load more HOT NEWS BooHoo Is Selling Bras With Subtle Patterns To Help You Check... Shannen Doherty Reveals She Has Stage IV Breast Cancer Addressing Cancer Disparities and New Research in Treating HPV-Positive Head and... EMA Recommends Extension of Indications for Tafasitamab
